Literature DB >> 1929256

Hippocampal activity in the presence of quinolones and fenbufen in vitro.

W Dimpfel1, M Spüler, A Dalhoff, W Hofmann, G Schlüter.   

Abstract

Rare side effects on the central nervous system including dizziness, restlessness, and even very rare convulsions as reported during the course of antibiotic treatment with quinolones were the topic of a well-controlled in vitro approach. The excitability of brain matter was tested by electrically evoking field potentials in the CA1 region of the rat hippocampus in vitro. Direct effects of nalidixic acid, enoxacin, pefloxacin, norfloxacin, ofloxacin, and ciprofloxacin were found to occur as a dose-dependent increase in amplitude of this field potential, which is in line with the view that the quinolones increase excitability. The highest increase was found with enoxacin and nalidixic acid, and the lowest increase was found with ciprofloxacin. In order to keep the potential risk of the antibiotic therapy as low as possible, ciprofloxacin might be the drug of choice of the quinolones. In contrast to the quinolones, which only increased the amplitudes of electrically evoked potentials, fenbufen induced spontaneous firing in the pyramidal cell layer without stimulation in addition to its dose-dependent effects on the amplitudes of the evoked potentials. Threshold doses of the quinolones tested (0.25 microM) increased the amplitudes of evoked potentials in the presence of an otherwise ineffective concentration of fenbufen (1 microM) to different degrees, ranging from 39.2% for ciprofloxacin to 72.6% for enoxacin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1929256      PMCID: PMC284301          DOI: 10.1128/AAC.35.6.1142

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

Review 1.  The use of in vitro brain slices for multidisciplinary studies of synaptic function.

Authors:  G Lynch; P Schubert
Journal:  Annu Rev Neurosci       Date:  1980       Impact factor: 12.449

2.  A simple perfusion chamber for the study of nervous tissue slices in vitro.

Authors:  H L Haas; B Schaerer; M Vosmansky
Journal:  J Neurosci Methods       Date:  1979-12       Impact factor: 2.390

3.  Electrical activities in thin sections from the mammalian brain maintained in chemically-defined media in vitro.

Authors:  C Yamamoto; H McIlwain
Journal:  J Neurochem       Date:  1966-12       Impact factor: 5.372

4.  Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor.

Authors:  S Segev; M Rehavi; E Rubinstein
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

5.  Inhibitory effects of quinolone antibacterial agents on gamma-aminobutyric acid binding to receptor sites in rat brain membranes.

Authors:  A Tsuji; H Sato; Y Kume; I Tamai; E Okezaki; O Nagata; H Kato
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

6.  Pro-convulsant actions of theophylline and caffeine in the hippocampus: implications for the management of temporal lobe epilepsy.

Authors:  B Ault; M A Olney; J L Joyner; C E Boyer; M A Notrica; F E Soroko; C M Wang
Journal:  Brain Res       Date:  1987-11-17       Impact factor: 3.252

  6 in total
  9 in total

Review 1.  Tolerability of fluoroquinolone antibiotics. Past, present and future.

Authors:  P Ball; G Tillotson
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

2.  Effects of novel 6-desfluoroquinolones and classic quinolones on pentylenetetrazole-induced seizures in mice.

Authors:  A De Sarro; V Cecchetti; V Fravolini; F Naccari; O Tabarrini; G De Sarro
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

3.  Convulsant and subconvulsant doses of norfloxacin in the presence and absence of biphenylacetic acid alter extracellular hippocampal glutamate but not gamma-aminobutyric acid levels in conscious rats.

Authors:  I Smolders; C Gousseau; S Marchand; W Couet; G Ebinger; Y Michotte
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

4.  In vitro modulation of hippocampal pyramidal cell response by quinolones: effects of HA 966 and gamma-hydroxybutyric acid.

Authors:  W Dimpfel; A Dalhoff; E von Keutz
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

5.  Quinolones potentiate cefazolin-induced seizures in DBA/2 mice.

Authors:  A De Sarro; M Zappalá; A Chimirri; S Grasso; G B De Sarro
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

6.  Determination of the excitatory potencies of fluoroquinolones in the central nervous system by an in vitro model.

Authors:  G Schmuck; A Schürmann; G Schlüter
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

7.  Involvement of inhibitory and excitatory neurotransmitters in levofloxacin- and ciprofloxacin-induced convulsions in mice.

Authors:  K Akahane; M Kato; S Takayama
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

8.  Effects of rasagiline, its metabolite aminoindan and selegiline on glutamate receptor mediated signalling in the rat hippocampus slice in vitro.

Authors:  W Dimpfel; J A Hoffmann
Journal:  BMC Pharmacol       Date:  2011-02-21

9.  Assessing the Quality and Potential Efficacy of Commercial Extracts of Rhodiola rosea L. by Analyzing the Salidroside and Rosavin Content and the Electrophysiological Activity in Hippocampal Long-Term Potentiation, a Synaptic Model of Memory.

Authors:  Wilfried Dimpfel; Leonie Schombert; Alexander G Panossian
Journal:  Front Pharmacol       Date:  2018-05-24       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.